RAS AL KHAIMAH, 17th August, 2026 (WAM) -- H.H. Sheikh Saud bin Saqr Al Qasimi, Supreme Council Member and Ruler of Ras Al Khaimah, today received the top-performing high school students for the ...

Unmanned Surface Vessel Division 12 (Sea Hunter) and 13 (Sea Hunter) conduct unit level training underway in San Diego Bay, California, May 1, 2025. US Navy photo The Navy’s portfolio acquisition ...

Pancreatic cancer remains one of the most difficult malignancies to treat. The unmet need is clear, but so is the risk of drug development in a disease where progress has often been limited. For Alan ...

Authorities confirm deaths, say 66 injured Authorities say a 'technical accident' caused explosion Blast occurred during restart at Barzan gas supply facility DOHA, June 22 (Reuters) - Thirteen people ...

b RAS G12, G13 or Q61 mut or no RAS mut identified. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting II. This abstract does not include a full text component.

This year’s meeting of the American Society of Clinical Oncology is abuzz with talk of RAS inhibitors, largely driven by Revolution Medicines’ barnburner pancreatic cancer data drop earlier this year.

Current therapies offer limited benefit for patients with previously treated metastatic pancreatic ductal adenocarcinoma (mPDAC). Aberrant activation of the RAS pathway is the key driver of PDAC, with ...

“We are pleased to hear of the gains being made in Newark Public Schools and to see that progress being recognized nationally for the academic strides our students are making. This reflects the hard ...

Students are already using AI to study. The real question is whether the AI they’re using is designed to support learning or just give them the answer. Many commonly used tools aren’t designed for ...

Dan Fetsco, sponsor of the Pre-Law living learning community, poses with Resident Assistant Destiny Roberts, a 2026 Hall to Home Award winner. (Mollie Hand Photo) The University of Wyoming Learning ...

After debunking earlier rumors that it was acquiring RAS superstar Revolution Medicines, AbbVie is now taking a more definitive step into the red-hot cancer field. The Chicago pharma has agreed to ...